
Turkish pharma company, Er-Kim, has signed a distribution agreement with CNX Therapeutics to expand access to a portfolio of oncology …

Diurnal Group, a specialty pharmaceutical company targeting patient needs in chronic endocrine diseases, has announced a distribution agreement with Er-Kim, …
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion

